Cargando…
Diagnostic and economic evaluation of new biomarkers for Alzheimer’s disease: the research protocol of a prospective cohort study
BACKGROUND: New research criteria for the diagnosis of Alzheimer’s disease (AD) have recently been developed to enable an early diagnosis of AD pathophysiology by relying on emerging biomarkers. To enable efficient allocation of health care resources, evidence is needed to support decision makers on...
Autores principales: | Handels, Ron LH, Aalten, Pauline, Wolfs, Claire AG, OldeRikkert, Marcel, Scheltens, Philip, Visser, Pieter Jelle, Joore, Manuela A, Severens, Johan L, Verhey, Frans RJ |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460756/ https://www.ncbi.nlm.nih.gov/pubmed/22883691 http://dx.doi.org/10.1186/1471-2377-12-72 |
Ejemplares similares
-
Optimizing the use of expert panel reference diagnoses in diagnostic studies of multidimensional syndromes
por: Handels, Ron L H, et al.
Publicado: (2014) -
Variability of CSF Alzheimer’s Disease Biomarkers: Implications for Clinical Practice
por: Vos, Stephanie J. B., et al.
Publicado: (2014) -
Performance of the EQ-5D and the EQ-5D+C in elderly patients with cognitive impairments
por: Wolfs, Claire AG, et al.
Publicado: (2007) -
Implementation of a diagnostic decision aid for people with memory complaints and their general practitioners: a protocol of a before and after pilot trial
por: Linden, Iris, et al.
Publicado: (2021) -
Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer’s Disease
por: Geijselaers, Stefan L.C., et al.
Publicado: (2017)